Correlation Between CSL and Sartorius Stedim

Can any of the company-specific risk be diversified away by investing in both CSL and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CSL and Sartorius Stedim Biotech, you can compare the effects of market volatilities on CSL and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Sartorius Stedim.

Diversification Opportunities for CSL and Sartorius Stedim

-0.37

Correlation Coefficient

CSL  Sartorius Stedim

Very good diversification

The 3 months correlation between CSL and Sartorius is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding CSL and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of CSL i.e., CSL and Sartorius Stedim go up and down completely randomly.

Pair Corralation between CSL and Sartorius Stedim

Assuming the 90 days horizon CSL is expected to under-perform the Sartorius Stedim. In addition to that, CSL is 1.29 times more volatile than Sartorius Stedim Biotech. It trades about -0.12 of its total potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about 0.13 per unit of volatility. If you would invest  2,122  in Sartorius Stedim Biotech on August 19, 2025 and sell it today you would earn a total of  328.00  from holding Sartorius Stedim Biotech or generate 15.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CSL  vs.  Sartorius Stedim Biotech

CSL

Risk-Adjusted Performance

Weakest

Over the last 90 days CSL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Sartorius Stedim Biotech

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Sartorius Stedim showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CSL and Sartorius Stedim

The main advantage of trading using opposite CSL and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.

The idea behind CSL and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.